TOXICOLOGICAL PROFILE FOR CHROMIUM - Davidborowski.com
TOXICOLOGICAL PROFILE FOR CHROMIUM - Davidborowski.com TOXICOLOGICAL PROFILE FOR CHROMIUM - Davidborowski.com
CHROMIUM 1322. HEALTH EFFECTS2.3.2 Distribution2.3.2.1 Inhalation ExposureExamination of tissues from Japanese chrome platers and chromate refining workers at autopsy revealedhigher chromium levels in the hilar lymph node, lung, spleen, liver, kidney, and heart, compared tonormal healthy males (Teraoka 1981). Analysis of the chromium concentrations in organs and tissues atautopsy of a man who died of lung cancer 10 years after his retirement from working in a chromateproducing plant for 30 years revealed measurable levels in the brain, pharyngeal wall, lung, liver, aorta,kidney, abdominal rectal muscle, suprarenal gland, sternal bone marrow, and abdominal skin. The levelswere significantly higher than in five controls with no occupational exposure to chromium. The man hadbeen exposed mainly to chromium(VI), with lesser exposure to chromium(III) as the chromite ore (Hyodoet al. 1980). The levels of chromium were higher in the lungs, but not in the liver or kidneys, of autopsyspecimens from 21 smeltery and refinery workers in North Sweden compared with that for a controlgroup of 8 individuals. The amount of enrichment in the lungs decreased as the number of elapsed yearsbetween retirement and death increased (Brune et al. 1980). Tissues from three individuals having lungcancer who were industrially exposed to chromium were examined by Mancuso (1997b). One wasemployed for 15 years as a welder, a second worked for 10.2 years, and a third for 31.8 years in oremilling and preparations and boiler operations. The three cumulative chromium exposures for the threeworkers were 3.45, 4.59, and 11.38 mg/m 3 years, respectively. Tissues from the first worker wereanalyzed 3.5 years after last exposure, the second worker 18 years after, and the third worker 0.6 yearsafter last exposure. All tissues from the three workers had elevated levels of chromium with the possibleexception of neural tissues. Levels were orders of magnitude higher in lungs than other tissues. Thehighest lung level reported was 456 mg/10 g tissue in the first worker, 178 in the second worker, and1,920 for the third worker. There were significant chromium levels in the tissue of the second workereven though he had not been exposed to chromium for 18 years. Chromium concentrations in lungtissues from autopsy samples were 5 times higher in subjects who originated from the Ruhr andDortmund regions of Germany, where emissions of chromium are high, than in subjects from Munsterand vicinity. The lung concentrations of chromium increased with increasing age. Men had twice as highconcentrations of chromium in the lungs than did women, which may reflect the greater potential foroccupational exposure by men, the higher vital capacity of men, and possibly a greater history of smoking(Kollmeier et al. 1990).
CHROMIUM 1332. HEALTH EFFECTSChromium may be transferred to fetuses through the placenta and to infants via breast milk. Analysis ofchromium levels in women employees of a dichromate manufacturing facility in Russia during and afterpregnancy revealed that the exposed women had significantly higher levels of chromium in blood andurine during pregnancy, in umbilical cord blood, placentae, and breast milk at child birth, and in fetusesaborted at 12 weeks than did nonexposed controls (Shmitova 1980). The reliability of this study issuspect because the levels of chromium reported in the blood and urine of the control women were muchhigher than usual background levels of chromium in these biological fluids (see Section 5.5), perhaps dueto problems with analytical methods. Measurement of the chromium content in 255 samples from45 lactating American women revealed that most samples contained kidney > gastrointestinal tract > erythrocytes > liver >serum > testis > skin. Twenty-five days after dosing, the tissue distribution was lung > kidney >erythrocytes > testis > liver > serum > skin > gastrointestinal tract. Kidney, erythrocytes, and testismaintained their chromium levels for a period of 10–15 days before decreasing (Weber 1983). Thedistribution of chromium(VI) compared with chromium(III) was investigated in guinea pigs afterintratracheal instillation of potassium dichromate or chromium trichloride. At 24 hours after instillation,11% of the original dose of chromium from potassium dichromate remained in the lungs, 8% in theerythrocytes, 1% in plasma, 3% in the kidney, and 4% in the liver. The muscle, skin, and adrenal glandscontained only a trace. All tissue concentrations of chromium declined to low or nondetectable levels in140 days with the exception of the lungs and spleen. After chromium trichloride instillation, 69% of thedose remained in the lungs at 20 minutes, while only 4% was found in the blood and other tissues, withthe remaining 27% cleared from the lungs and swallowed. The only tissue that contained a significantamount of chromium 2 days after instillation of chromium trichloride was the spleen. After 30 and60 days, 30 and 12%, respectively, of the chromium(III) was retained in the lungs, while only 2.6 and1.6%, respectively, of the chromium(VI) dose was retained in the lung (Baetjer et al. 1959a).
- Page 102 and 103: Neurological45 Rat 28 d(Wistar)Repr
- Page 104 and 105: 59 Mouse 85 d + 36.7 F NTP 1997(BAL
- Page 106 and 107: CHRONIC EXPOSURESystemic70 Human71
- Page 108 and 109: Figure 2-2. Levels of Significant E
- Page 110 and 111: MinimalFigure 2-2. Levels of Signif
- Page 112 and 113: CHROMIUM 922. HEALTH EFFECTSand blo
- Page 114 and 115: CHROMIUM 942. HEALTH EFFECTSHematol
- Page 116 and 117: CHROMIUM 962. HEALTH EFFECTSAverage
- Page 118 and 119: CHROMIUM 982. HEALTH EFFECTSchanges
- Page 120 and 121: CHROMIUM 1002. HEALTH EFFECTSsperma
- Page 122 and 123: CHROMIUM 1022. HEALTH EFFECTSchromi
- Page 124 and 125: CHROMIUM 1042. HEALTH EFFECTS2.2.2.
- Page 126 and 127: CHROMIUM 1062. HEALTH EFFECTSImpair
- Page 128 and 129: CHROMIUM 1082. HEALTH EFFECTSrates
- Page 130 and 131: TABLE 2-3. Levels of Significant Ex
- Page 132 and 133: HumanHumanHumanHumanHumanHumanHuman
- Page 134 and 135: CHRONIC EXPOSURESystemicHuman 7.5 y
- Page 136 and 137: CHROMIUM 1162. HEALTH EFFECTSNo stu
- Page 138 and 139: CHROMIUM 1182. HEALTH EFFECTSIrrita
- Page 140 and 141: CHROMIUM 1202. HEALTH EFFECTSindust
- Page 142 and 143: CHROMIUM 1222. HEALTH EFFECTSGuinea
- Page 144 and 145: CHROMIUM 1242. HEALTH EFFECTSmodel,
- Page 146 and 147: CHROMIUM 1262. HEALTH EFFECTSblood,
- Page 148 and 149: CHROMIUM 1282. HEALTH EFFECTSchromi
- Page 150 and 151: CHROMIUM 1302. HEALTH EFFECTSAlthou
- Page 154 and 155: CHROMIUM 1342. HEALTH EFFECTS2.3.2.
- Page 156 and 157: CHROMIUM 1362. HEALTH EFFECTSThe di
- Page 158 and 159: CHROMIUM 1382. HEALTH EFFECTS(2-5 m
- Page 160 and 161: CHROMIUM 1402. HEALTH EFFECTSIn rat
- Page 162 and 163: CHROMIUM 1422. HEALTH EFFECTSunstab
- Page 164 and 165: CHROMIUM 1442. HEALTH EFFECTSIn add
- Page 166 and 167: CHROMIUM 1462. HEALTH EFFECTSsignif
- Page 168 and 169: CHROMIUM 1482. HEALTH EFFECTS2.3.4.
- Page 170 and 171: CHROMIUM 1502. HEALTH EFFECTSDaily
- Page 172 and 173: CHROMIUM 1522. HEALTH EFFECTS51 Chr
- Page 174 and 175: CHROMIUM 1542. HEALTH EFFECTS2.3.5
- Page 176 and 177: CHROMIUM 1562. HEALTH EFFECTSFigure
- Page 178 and 179: CHROMIUM 1582. HEALTH EFFECTSTable
- Page 180 and 181: CHROMIUM 1602. HEALTH EFFECTSFigure
- Page 182 and 183: CHROMIUM 1622. HEALTH EFFECTSInterr
- Page 184 and 185: CHROMIUM 1642. HEALTH EFFECTSthe bl
- Page 186 and 187: CHROMIUM 1662. HEALTH EFFECTSpreval
- Page 188 and 189: CHROMIUM 1682. HEALTH EFFECTS2.5 RE
- Page 190 and 191: CHROMIUM 1702. HEALTH EFFECTSSevera
- Page 192 and 193: CHROMIUM 1722. HEALTH EFFECTSanimal
- Page 194 and 195: CHROMIUM 1742. HEALTH EFFECTSOral M
- Page 196 and 197: CHROMIUM 1762. HEALTH EFFECTSfibros
- Page 198 and 199: CHROMIUM 1782. HEALTH EFFECTSNausea
- Page 200 and 201: CHROMIUM 1802. HEALTH EFFECTSthe pr
<strong>CHROMIUM</strong> 1322. HEALTH EFFECTS2.3.2 Distribution2.3.2.1 Inhalation ExposureExamination of tissues from Japanese chrome platers and chromate refining workers at autopsy revealedhigher chromium levels in the hilar lymph node, lung, spleen, liver, kidney, and heart, <strong>com</strong>pared tonormal healthy males (Teraoka 1981). Analysis of the chromium concentrations in organs and tissues atautopsy of a man who died of lung cancer 10 years after his retirement from working in a chromateproducing plant for 30 years revealed measurable levels in the brain, pharyngeal wall, lung, liver, aorta,kidney, abdominal rectal muscle, suprarenal gland, sternal bone marrow, and abdominal skin. The levelswere significantly higher than in five controls with no occupational exposure to chromium. The man hadbeen exposed mainly to chromium(VI), with lesser exposure to chromium(III) as the chromite ore (Hyodoet al. 1980). The levels of chromium were higher in the lungs, but not in the liver or kidneys, of autopsyspecimens from 21 smeltery and refinery workers in North Sweden <strong>com</strong>pared with that for a controlgroup of 8 individuals. The amount of enrichment in the lungs decreased as the number of elapsed yearsbetween retirement and death increased (Brune et al. 1980). Tissues from three individuals having lungcancer who were industrially exposed to chromium were examined by Mancuso (1997b). One wasemployed for 15 years as a welder, a second worked for 10.2 years, and a third for 31.8 years in oremilling and preparations and boiler operations. The three cumulative chromium exposures for the threeworkers were 3.45, 4.59, and 11.38 mg/m 3 years, respectively. Tissues from the first worker wereanalyzed 3.5 years after last exposure, the second worker 18 years after, and the third worker 0.6 yearsafter last exposure. All tissues from the three workers had elevated levels of chromium with the possibleexception of neural tissues. Levels were orders of magnitude higher in lungs than other tissues. Thehighest lung level reported was 456 mg/10 g tissue in the first worker, 178 in the second worker, and1,920 for the third worker. There were significant chromium levels in the tissue of the second workereven though he had not been exposed to chromium for 18 years. Chromium concentrations in lungtissues from autopsy samples were 5 times higher in subjects who originated from the Ruhr andDortmund regions of Germany, where emissions of chromium are high, than in subjects from Munsterand vicinity. The lung concentrations of chromium increased with increasing age. Men had twice as highconcentrations of chromium in the lungs than did women, which may reflect the greater potential foroccupational exposure by men, the higher vital capacity of men, and possibly a greater history of smoking(Kollmeier et al. 1990).